Clinical Hepatology 2019
DOI: 10.1136/gutjnl-2019-iddfabstracts.305
|View full text |Cite
|
Sign up to set email alerts
|

IDDF2019-ABS-0305 Psoas muscle thickness as measure for sarcopenia and prognosis in liver cirrhosis

Abstract: Background Malnutrition is an overlooked complication of liver cirrhosis. Sarcopenia, a marker of malnutrition, is an independent prognostic factor for mortality in liver cirrhosis.We aimed to evaluate psoas muscle thickness divided by height (PMTH) as a measure for the degree of sarcopenia and determine its correlation with the clinical outcomes. Methods Sixty-five liver cirrhosis patients with available abdominal CT scan were reviewed in this retrospective cohort study. PMTH were measured and correlated with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Recently, several studies reported single muscle, rather than total skeletal muscle, mass for sarcopenia assessment [ 11 , 21 ]. The most commonly used individual muscle for sarcopenia diagnosis is the psoas muscle.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, several studies reported single muscle, rather than total skeletal muscle, mass for sarcopenia assessment [ 11 , 21 ]. The most commonly used individual muscle for sarcopenia diagnosis is the psoas muscle.…”
Section: Discussionmentioning
confidence: 99%
“…A single-muscle approach to be used clinically for the diagnosis of sarcopenia is a recent trend in the literature on CT-defined muscle quantification [ 10 ] Currently, the psoas muscle is one of the most common muscles for the diagnosis of sarcopenia [ 11 ]. However, whether psoas muscle also predict survival is not known.…”
Section: Introductionmentioning
confidence: 99%
“…Sarcopenic COPD patients reduced peak inspiratory flow, peak expiratory flow, and CAT score compared to non-sarcopenic COPD patients (Chua et al, 2019). No significant difference in the PMTH values between cirrhotic patients without HCCA and those with HCCA (Tan et al, 2019). Sarcopenic COPD patients' diagnosis was associated with osteoporosis; they also have lower HGS compared to nonsarcopenic COPD patients (Chua & Tee, 2020).…”
Section: Aspect Outcomesmentioning
confidence: 86%